Published in Am J Surg Pathol on October 01, 2012
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest (2001) 5.72
An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature (2002) 2.33
The transferrin receptor: role in health and disease. Int J Biochem Cell Biol (1999) 2.02
Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest (2004) 1.65
Megakaryocyte biology and related disorders. J Clin Invest (2005) 1.23
MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocythemia. Platelets (2009) 1.05
Role of alpha-hemoglobin-stabilizing protein in normal erythropoiesis and beta-thalassemia. Ann N Y Acad Sci (2005) 0.97
E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol (1995) 0.97
CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol (2010) 0.95
Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. PLoS One (2010) 0.94
Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis. Exp Hematol (2008) 0.87
Loss of membrane expression of E-cadherin in leukemic erythroblasts. Arch Pathol Lab Med (2001) 0.87
CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A. Am J Surg Pathol (2011) 0.87
Alpha-hemoglobin-stabilizing protein: an erythroid molecular chaperone. Biochem Res Int (2011) 0.85
Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection. Int J Hematol (2001) 0.82
ALDH, CA I, and CD2AP: novel, diagnostically useful immunohistochemical markers to identify erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol (2012) 0.79
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med (2011) 18.99
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med (2011) 12.58
Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1. Mol Cell (2005) 5.77
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab (2003) 5.27
Global regulation of erythroid gene expression by transcription factor GATA-1. Blood (2004) 4.22
An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol (2012) 4.15
Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem (2003) 3.93
GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A (2003) 3.32
A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci U S A (2008) 3.10
Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell (2009) 3.05
Mitoferrin is essential for erythroid iron assimilation. Nature (2006) 2.99
Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood (2003) 2.93
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Blood (2013) 2.91
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma. N Engl J Med (2015) 2.77
Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res (2009) 2.64
GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol (2003) 2.52
An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature (2002) 2.33
Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1. Mol Cell Biol (2003) 2.09
Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration. Genome Res (2011) 2.07
Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell (2012) 1.94
Cooperative activities of hematopoietic regulators recruit RNA polymerase II to a tissue-specific chromatin domain. Proc Natl Acad Sci U S A (2002) 1.91
Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol (2007) 1.90
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood (2013) 1.82
miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev (2010) 1.80
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood (2013) 1.73
Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. Blood (2005) 1.72
Experimental validation of predicted mammalian erythroid cis-regulatory modules. Genome Res (2006) 1.71
Utility of FDG-PET scanning in lymphoma by WHO classification. Blood (2003) 1.69
Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation. Mol Cell Biol (2005) 1.67
Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest (2004) 1.65
Coexisting follicular and mantle cell lymphoma with each having an in situ component: A novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma. Am J Clin Pathol (2010) 1.65
Transcriptional enhancement by GATA1-occupied DNA segments is strongly associated with evolutionary constraint on the binding site motif. Genome Res (2008) 1.58
Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.54
B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med (2007) 1.53
A hemoglobin variant associated with neonatal cyanosis and anemia. N Engl J Med (2011) 1.48
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia. Clin Cancer Res (2008) 1.48
Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood (2008) 1.47
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A (2012) 1.46
Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes. Am J Hematol (2005) 1.43
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia. Clin Cancer Res (2009) 1.42
LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev Cell (2009) 1.39
Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin. Cell (2004) 1.39
Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia? Am J Hematol (2002) 1.37
Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development. Blood (2014) 1.34
An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. J Clin Invest (2007) 1.30
Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood (2003) 1.30
Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood (2009) 1.28
STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J Clin Invest (2007) 1.27
Megakaryocyte biology and related disorders. J Clin Invest (2005) 1.23
Structure of oxidized alpha-haemoglobin bound to AHSP reveals a protective mechanism for haem. Nature (2005) 1.22
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica (2011) 1.22
Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn (2007) 1.20
Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity. J Virol (2002) 1.20
Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. Blood (2013) 1.20
Biophysical characterization of the alpha-globin binding protein alpha-hemoglobin stabilizing protein. J Biol Chem (2002) 1.20
MicroRNAs in erythropoiesis. Curr Opin Hematol (2010) 1.15
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Mol Cell Biol (2009) 1.13
MicroRNA expression in maturing murine megakaryocytes. Blood (2010) 1.12
The evolution of molecular genetic pathology: advancing 20th-century diagnostic methods into potent tools for the new millennium. J Mol Diagn (2008) 1.11
Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice. J Mol Diagn (2003) 1.10
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood (2014) 1.10
Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res (2012) 1.09
CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. J Clin Invest (2012) 1.09
Hemoglobin variants: biochemical properties and clinical correlates. Cold Spring Harb Perspect Med (2013) 1.09
miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol (2012) 1.08
Alpha-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. Br J Haematol (2006) 1.06
Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia. Blood (2012) 1.05
A comparative analysis of molecular genetic and conventional cytogenetic detection of diagnostically important translocations in more than 400 cases of acute leukemia, highlighting the frequency of false-negative conventional cytogenetics. Am J Clin Pathol (2011) 1.04
Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. Blood (2004) 1.04
Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. J Pediatr (2009) 1.01
Protein quality control during erythropoiesis and hemoglobin synthesis. Hematol Oncol Clin North Am (2010) 1.01
What's in a name? J Clin Invest (2012) 0.98
Identification of distal cis-regulatory elements at mouse mitoferrin loci using zebrafish transgenesis. Mol Cell Biol (2011) 0.97
Cell division rates of primary human precursor B cells in culture reflect in vivo rates. Stem Cells (2004) 0.97
The secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesis. Blood (2013) 0.96
An iron responsive element-like stem-loop regulates alpha-hemoglobin-stabilizing protein mRNA. J Biol Chem (2008) 0.96
Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cytometry B Clin Cytom (2005) 0.96
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management. Cancer Biol Ther (2007) 0.94
Biochemical fates of alpha hemoglobin bound to alpha hemoglobin-stabilizing protein AHSP. J Biol Chem (2006) 0.94
Intravascular large B-cell lymphoma: a mimicker of many maladies and a difficult and often delayed diagnosis. J Clin Oncol (2010) 0.94
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Am J Hematol (2008) 0.93
Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation. J Biol Chem (2011) 0.93
Designer blood: creating hematopoietic lineages from embryonic stem cells. Blood (2005) 0.93
Analysis of human alpha globin gene mutations that impair binding to the alpha hemoglobin stabilizing protein. Blood (2009) 0.92
The role of alpha-hemoglobin stabilizing protein in redox chemistry, denaturation, and hemoglobin assembly. Antioxid Redox Signal (2010) 0.92
Kinetics of α-globin binding to α-hemoglobin stabilizing protein (AHSP) indicate preferential stabilization of hemichrome folding intermediate. J Biol Chem (2012) 0.90
IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue. Hum Pathol (2009) 0.90
A new 'Linc' between noncoding RNAs and blood development. Genes Dev (2011) 0.89
A cis-proline in alpha-hemoglobin stabilizing protein directs the structural reorganization of alpha-hemoglobin. J Biol Chem (2009) 0.89
Long noncoding RNAs in biology and hematopoiesis. Blood (2013) 0.88
Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. Am J Hematol (2008) 0.88
Hematopoietic differentiation of pluripotent stem cells in culture. Methods Mol Biol (2014) 0.88
Isolated bowel relapse in acute promyelocytic leukemia: an unusual site of extramedullary recurrence. J Clin Oncol (2010) 0.87
α-Hemoglobin stabilizing protein (AHSP) markedly decreases the redox potential and reactivity of α-subunits of human HbA with hydrogen peroxide. J Biol Chem (2012) 0.87
GATA-1 and Oct-1 are required for expression of the human alpha-hemoglobin-stabilizing protein gene. J Biol Chem (2005) 0.86
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica (2014) 0.86
Myelodysplastic syndromes. Contemporary biologic concepts and emerging diagnostic approaches. Am J Clin Pathol (2003) 0.85